The Preservation Conversation

Discussions about possible infertility in young patients with cancer should happen early, and often. Chemotherapy, radiation, and hematopoietic cell transplantation (HCT) are essential treatment options for patients with hematologic malignancies, but these therapies often harm...

Online Exclusives

Female Physicians Face Higher Rates of Infertility and Pregnancy Complications

As female physicians tend to delay pregnancy until after their residencies, they are more susceptible to fertility issues. Nearly one in four female physicians...

After a Pandemic-Driven Boom, Telehealth Visits Level Off

According to recent data, telehealth visits are leveling off from their pandemic highs to below 20% of total medical appointments. Overall telehealth use for doctor’s...

News

From the Blood Journals

WIB_icon

Asciminib Superior to Bosutinib in Chronic-Phase CML

Asciminib was more effective than bosutinib at improving the rate of a major molecular response in patients with chronic myeloid leukemia in chronic phase...

Early Catheter Removal Does Not Increase Risk of PE

Among patients with a hematologic malignancy and central venous catheter (CVC)–associated upper extremity deep vein thrombosis (UEDVT), removing CVCs within 48 hours of diagnosis...

Multimedia

Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...

Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...

Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...

Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.

Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...

Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.

On Location

On location

Investigating the Combination of Ivosidenib Plus Venetoclax and Azacitidine in IDH-Mutated Myeloid Malignancies

In a small study of patients with IDH1-mutated myeloid malignancies, treatment with ivosidenib plus venetoclax, with or without azacitidine,...
On location

Evaluating Two New Options for Hereditary Hemorrhagic Telangiectasia

At EHA2021 Virtual, researchers shared safety and efficacy findings of two agents for the treatment...
On location

Ibrutinib Plus Rituximab Shows Efficacy in Indolent Mantle Cell Lymphoma

In the GELTAMO ICML-2015 study, treatment with frontline ibrutinib in combination with rituximab demonstrated high...
On location

Evaluating a Response-Adapted Rituximab Approach for Patients With Follicular Lymphoma

In patients with follicular lymphoma (FL), standard rituximab maintenance produced better rates of progression-free survival...
On location

Does Khorana Score Accurately Predict VTE in Patients With Uterine and Ovarian Cancer?

At the 2021 ASCO Annual Meeting, researchers shared results from two studies examining the Khorana...
On location

PDE9 Inhibitor Shows Promise as Monotherapy and With Hydroxyurea in Sickle Cell Disease

Data from two new studies indicated that daily dosing of the oral phosphodiesterase type 9...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Announces New ASH-AMFDP Hematology Scholars, First 10 Sites Join ASH Research Collaborative SCD...

ASH Publishes Adapted Clinical Practice Guidelines for Management of VTE in Latin America The American Society of Hematology (ASH), in partnership with 12 Latin American...
ASH Directions

ASH Announces 2021 ASH Honorific Award Recipients, Issues New Guidance on Anticoagulation for Discharged...

Congratulations to the Recipients of the 2021 ASH Honorific Awards! The American Society of Hematology (ASH) has announced the recipients of its 2021 Honorific Awards,...

Sign up for our
eNewsletter!

The Society Pages

Remembering Alvin Zipursky, Paul Frenette, and more

Remembering Alvin Zipursky (1930 – 2021) Alvin Zipursky, MD, a leader in the field of pediatric hematology, died on August 10.Dr. Zipursky was professor emeritus...
The Society Pages

ASH Remembers Joel S. Bennett, Cancer Researchers Win Damon Runyon Physician-Scientist Training Awards, and...

Remembering Joel S. Bennett (1942 – 2021) Joel S. Bennett, MD, died of pancreatic cancer on June 21, 2021, at the age of 78.Aside from...
The Society Pages

SAACR Awards Indian Americans for Cancer Research Discoveries, GBT Awards $450k to SCD Care...

Catherine Bollard Recognized for Mentorship and Cell-Based Therapy Research Catherine Bollard, MD, MBChB, director of the Center for Cancer and Immunology Research at Children’s National...

The Preservation Conversation

Discussions about possible infertility in young patients with cancer should happen early, and often. Chemotherapy, radiation, and hematopoietic cell transplantation (HCT) are essential treatment options...

The Eye of a Survivor

While cure remains a goal, unique issues arise when treating professional and amateur athletes for hematologic conditions. Athletic competition on an elite level depends on...

Transforming Ideas into Research Reality

Participants come to the ASH Clinical Research Training Institute with ideas and enthusiasm, and leave with new skills to conduct patient-oriented research. Just 20 years...